Economic Evaluation of Lenograstim (Glycosylated rHuG-CSF) in the Treatment of Inflammatory Breast Cancer for Germany and Italy
- 1 January 1994
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 6 (2) , 27-35
- https://doi.org/10.2165/00019053-199400062-00006
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- In vivo stimulation of neutrophil function by lenograstim (glycosylated rHug‐CSF) in oncohematologic patients: Results of a phase I trialThe International Journal of Cell Cloning, 1994
- Methodological Issues in Economic Assessments of New TherapiesPharmacoEconomics, 1994
- Inflammatory Breast CancerArchives of Surgery, 1991
- Management of locally advanced and inflammatory carcinoma of the breast.1985